Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jorge Conde, James Evans

Premium

Knome's Co-founder Jorge Conde has joined Syros Pharmaceuticals as CFO and chief product officer where he will lead the platform strategy for Syros' novel gene regulation technology and manage the overall finances for the company. Conde most recently served as Knome's CFO, but has also worked in marketing and operations at MedImmune, as well as at Helicos Biosciences. Previously, he was an investment banker at Morgan Stanley.


Myriad's CFO James Evans has retired, but will continue to serve as CFO until the company finds a replacement. He joined Myriad in 1995 as a corporate controller and was promoted to vice president of finance in 2005. In 2007, he was named CFO.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.